RE:RE:RE:Level 2 - PleaseG1945V
You must be referring to Craig Goodwin. Not sure who Gordon, or Gord is.
I agree with you on the budget and advertising but not on the Cavaltinib.
Cavaltinib has already been produced with 100's of bottles sitting on the shelves at NSP waiting for the trial acceptance and delivery. (or so they claim!) They produced that inventory early last year when Covid hit.
For Cavaltinib, all NSP had to do is mark it up and flip it. Rhema Corp. around the corner from them makes it for them on behalf of Biologics.
The product is the stronger version (with a couple of other minimal ingredients) of the Pro Curc 30 and Natera 50 they buy and flip from the same supplier. The only overhead is the shelf space with large mark up and delivery cost,
The problem is NSP Mgmt. are not seeing the big picture.
Based on other third party BDMC research, they have a very important natural product here that could save lives and reduce the severe Cytokine storm in the lungs of Covid-19 patience. (and that is based on other third-party research, not their own basic research. (Always look past their claims to minimum two other sources)
Just look at one other product with basic curcumin in it that got proven late last year as a Covid-19 Treatment. LifeTech partner Swiss Pharmacan AG, and MGC Pharma (“MGC”) announced the full results of their Phase II double-blind, placebo-controlled clinical trial for anti-inflammatory treatment ArtemiC™, powered by MyCell Technology™, on persons diagnosed with COVID-19, It successfully met all the Phase II primary and secondary endpoints and demonstrated to improve the clinical recovery of COVID-19 patients.
ArtemiC™ is a natural anti-inflammatory formulation by MGC Pharma, which is powered by Mycell Technology™, the same delivery system technology that Glow LifeTech has the exclusive North American (US, Canada, Mexico) license to manufacture, sell and market for cannabis and certain nutraceutical ingredients. The natural formulation, jointly developed by Glow partner Swiss PharmaCan, is based on four MyCell™ enhanced ingredients: Artemisinin, Curcumin, Vitamin c, and Boswellia Serrata, which are well-known natural active ingredients with anti-inflammatory properties. The formulation is intended to suppress the cytokine storm and clinical deterioration to support the recovery of COVID-19 patients.
ArtemiC™ only has the basic Curcumin analogues in it with less than 5% BDMC, Bisdemethoxycurcumin. And it works. BDMC is the curcumin active ingredient that makes it work.
Cavaltinib is much, much stronger with the active BDMC ingredient that does all the inflammation suppression and normalization at over 50% BDMC. Pro Curc has 30% BDMC and I can tell you personally it can stop early Covid-19 symptoms in its tracks. If ArtemiC™ can do it with standard and very small amount of Curcumin, imagine what Cavaltinib can do with a more targeted and more powerful dose of curcumin BDMC.
I know it works, I have been knocking down sore throats and respiratory issues off and on for month now with the Pro Curc 30. I am confident the 50% or higher prescription based Cavaltinib will do what they claim it will do but based on the delay from NSP and Biologics, I do not think they even know what they have. (A license to print $$$ money!)
That is the frustrating part as here we are 8 months after their initial statement for “fast tracking” this product and they are just hopefully getting the Phase II trial started. They could have even received grant money from the Federal Government for this and didn’t. As I look at the vaccine this basically does the same thing with natural ingredients and no chemicals mix.
The concerning part is also the $500,00.00 to be allocated to this in tranches, It is not to build out pie in the sky vegan manufacturing plant or to pay off Director consultant fees. They can outsource that like they do themselves as inexperienced consultants. Craig and Bryan are legal partners in that venture and need to commit that money to the project if they have not done so as yet.
These guys need to realize they have shareholders out here that are watching them very closely.
Keep the Vegan containers coming for now, mark up and flip the products and get the revenue up to where this company actually makes a profit.
Stop spending money like drunken sailors and make this happen. I would do it myself but the guy from Biologics owns the patent on this product.
Sorry for the long winded “rant” but getting very frustrated as the Covid-19 numbers keep climbing and this company keeps delaying.
Curc out